1,2-dichloroethane decreases expression ISO RGD:733454 6480464 ethylene dichloride results in decreased expression of FABP4 mRNA CTD PMID:28189721 1,2-dimethylhydrazine multiple interactions ISO RGD:69309 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of FABP4 mRNA CTD PMID:27840820 1,3,5-trinitro-1,3,5-triazinane decreases expression ISO RGD:69309 6480464 cyclonite results in decreased expression of FABP4 mRNA CTD PMID:25559034 1,4-bis(2-ethylhexyl) sulfosuccinate increases expression ISO RGD:733454 6480464 Dioctyl Sulfosuccinic Acid results in increased expression of FABP4 mRNA CTD PMID:26135921 1-naphthyl isothiocyanate increases expression ISO RGD:69309 6480464 1-Naphthylisothiocyanate results in increased expression of FABP4 mRNA CTD PMID:30723492 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 [15-deoxy-delta(12, 14)-prostaglandin J2 co-treated with Tretinoin] results in increased expression of FABP4 mRNA CTD PMID:16573735 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:733454 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of FABP4 mRNA CTD PMID:12021203 , PMID:9543393 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression EXP 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of FABP4 mRNA CTD PMID:16573735 17alpha-ethynylestradiol increases expression ISO RGD:733454 6480464 Ethinyl Estradiol results in increased expression of FABP4 mRNA CTD PMID:17942748 17alpha-hydroxyprogesterone multiple interactions EXP 6480464 [17-alpha-Hydroxyprogesterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 17beta-estradiol decreases expression ISO RGD:733454 6480464 Estradiol results in decreased expression of FABP4 mRNA CTD PMID:16643890 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FABP4 mRNA CTD PMID:25878060 17beta-estradiol increases expression ISO RGD:733454 6480464 Estradiol results in increased expression of FABP4 mRNA CTD PMID:15713686 , PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein] CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of FABP4 mRNA, Dihydrotestosterone results in decreased expression of FABP4 protein CTD PMID:18801408 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:22262711 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733454 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:733454 6480464 2 more ... CTD PMID:24559133 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733454 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP4 mRNA CTD PMID:16960034 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FABP4 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP4 mRNA CTD PMID:20106945 , PMID:22262711 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733454 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP4 mRNA CTD PMID:15591033 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69309 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP4 mRNA CTD PMID:16960034 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733454 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:16054899 , PMID:30722647 2,4-diaminotoluene decreases expression ISO RGD:733454 6480464 2, 4-diaminotoluene results in decreased expression of FABP4 mRNA CTD PMID:22016648 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:733454 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO RGD:733454 6480464 2 more ... CTD PMID:30903904 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:733454 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:69309 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO RGD:733454 6480464 glucosamine 6-phosphate results in decreased expression of FABP4 mRNA CTD PMID:19427183 2-butoxyethanol increases expression ISO RGD:733454 6480464 n-butoxyethanol results in increased expression of FABP4 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of FABP4 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:22262711 , PMID:25304490 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:733454 6480464 tetrabromobisphenol A results in increased expression of FABP4 mRNA, tetrabromobisphenol A results in increased expression of FABP4 protein CTD PMID:25777084 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:733454 6480464 tetrabromobisphenol A results in decreased expression of FABP4 protein CTD PMID:28329833 3,3',5-triiodo-L-thyronine increases expression ISO RGD:69309 6480464 Triiodothyronine results in increased expression of FABP4 mRNA CTD PMID:15953391 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA] more ... CTD PMID:20206132 more ... 3-isobutyl-1-methyl-7H-xanthine increases expression EXP 6480464 1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69309 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of FABP4 mRNA CTD PMID:21350315 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:733454 6480464 1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA CTD PMID:9564879 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733454 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA] more ... CTD PMID:15273253 more ... 3-methylcholanthrene decreases expression ISO RGD:733454 6480464 Methylcholanthrene results in decreased expression of FABP4 mRNA CTD PMID:25926378 3-methylcholanthrene multiple interactions ISO RGD:733454 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FABP4 mRNA CTD PMID:25926378 3-phenylprop-2-enal increases expression EXP 6480464 cinnamic aldehyde results in increased expression of FABP4 mRNA CTD PMID:30806763 4,4'-diaminodiphenylmethane increases expression ISO RGD:733454 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FABP4 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression ISO RGD:69309 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FABP4 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 fulvestrant inhibits the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein] CTD PMID:27003841 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of FABP4 mRNA CTD PMID:30352284 4,4'-sulfonyldiphenol increases expression ISO RGD:733454 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 mRNA CTD PMID:30959087 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733454 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA] more ... CTD PMID:27273607 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein CTD PMID:27003841 , PMID:27685785 4-hydroxyphenyl retinamide decreases expression ISO RGD:733454 6480464 Fenretinide results in decreased expression of FABP4 mRNA CTD PMID:28973697 5-formyltetrahydrofolic acid multiple interactions ISO RGD:69309 6480464 Leucovorin inhibits the reaction [Methotrexate results in increased expression of FABP4 protein] CTD PMID:25187349 8-(4-chlorophenylthio)-cGMP increases expression ISO RGD:733454 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-GMP results in increased expression of FABP4 protein CTD PMID:20471953 8-(4-chlorophenylthio)-cGMP multiple interactions ISO RGD:733454 6480464 8-(4-chlorophenylthio)guanosine 3' more ... CTD PMID:20471953 [6]-Shogaol multiple interactions ISO RGD:733454 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of FABP4 mRNA] CTD PMID:18577375 [6]-Shogaol increases expression ISO RGD:733454 6480464 shogaol results in increased expression of FABP4 mRNA CTD PMID:18577375 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of FABP4 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:69309 6480464 Aflatoxin B1 results in increased expression of FABP4 mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucosamine increases expression ISO RGD:733454 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:69309 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 aldehydo-D-glucosamine 6-phosphate decreases expression ISO RGD:733454 6480464 glucosamine 6-phosphate results in decreased expression of FABP4 mRNA CTD PMID:19427183 aldehydo-D-glucose multiple interactions ISO RGD:733454 6480464 [Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA more ... CTD PMID:8536680 all-trans-retinoic acid multiple interactions EXP 6480464 [15-deoxy-delta(12 more ... CTD PMID:16573735 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of FABP4 mRNA CTD PMID:16054129 Aloe emodin multiple interactions EXP 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA] CTD PMID:22645054 ammonium chloride affects expression ISO RGD:69309 6480464 Ammonium Chloride affects the expression of FABP4 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:69309 6480464 Amphetamine results in increased expression of FABP4 mRNA CTD PMID:30779732 aniline increases expression ISO RGD:733454 6480464 aniline results in increased expression of FABP4 mRNA CTD PMID:22016648 anthracen-2-amine increases expression ISO RGD:69309 6480464 2-anthramine results in increased expression of FABP4 mRNA CTD PMID:23038007 arsane affects methylation EXP 6480464 Arsenic affects the methylation of FABP4 gene CTD PMID:25304211 arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of FABP4 gene CTD PMID:25304211 avobenzone multiple interactions EXP 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA] CTD PMID:31016361 baicalein decreases expression ISO RGD:733454 6480464 baicalein results in decreased expression of FABP4 protein CTD PMID:24560969 barium sulfate decreases expression ISO RGD:69309 6480464 Barium Sulfate results in decreased expression of FABP4 mRNA CTD PMID:29463257 benzbromarone increases expression ISO RGD:733454 6480464 Benzbromarone results in increased expression of FABP4 mRNA CTD PMID:19048458 benzene multiple interactions ISO RGD:733454 6480464 TRP53 protein affects the reaction [Benzene results in increased expression of FABP4 mRNA] CTD PMID:12928149 benzene increases expression ISO RGD:733454 6480464 Benzene results in increased expression of FABP4 mRNA CTD PMID:12928149 benzo[a]pyrene decreases expression ISO RGD:733454 6480464 Benzo(a)pyrene results in decreased expression of FABP4 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733454 6480464 Benzo(a)pyrene results in increased expression of FABP4 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO RGD:733454 6480464 [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA, AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of FABP4 mRNA] CTD PMID:15034205 , PMID:26271895 benzo[b]fluoranthene decreases expression ISO RGD:733454 6480464 benzo(b)fluoranthene results in decreased expression of FABP4 mRNA CTD PMID:26377693 Benzo[k]fluoranthene decreases expression ISO RGD:733454 6480464 benzo(k)fluoranthene results in decreased expression of FABP4 mRNA CTD PMID:26377693 benzofurans decreases expression ISO RGD:733454 6480464 Benzofurans results in decreased expression of FABP4 mRNA CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression EXP 6480464 benzylparaben results in increased expression of FABP4 mRNA CTD PMID:22956630 Benzyl parahydroxybenzoate increases expression ISO RGD:733454 6480464 benzylparaben results in increased expression of FABP4 mRNA CTD PMID:22956630 , PMID:27659731 berberine decreases expression EXP 6480464 Berberine results in decreased expression of FABP4 mRNA CTD PMID:26478571 berberine increases expression EXP 6480464 Berberine results in increased expression of FABP4 mRNA CTD PMID:29408570 berberine multiple interactions EXP 6480464 15-deoxyprostaglandin J2 promotes the reaction [Berberine results in increased expression of FABP4 mRNA], Berberine promotes the reaction [15-deoxyprostaglandin J2 results in increased expression of FABP4 mRNA] CTD PMID:29408570 berberine increases expression ISO RGD:733454 6480464 Berberine results in increased expression of FABP4 mRNA CTD PMID:29408570 beta-carotene decreases expression ISO RGD:733454 6480464 beta Carotene results in decreased expression of FABP4 mRNA CTD PMID:21569430 beta-D-glucosamine increases expression ISO RGD:733454 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:69309 6480464 Glucosamine results in increased expression of FABP4 mRNA CTD PMID:15694357 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:733454 6480464 glucosamine 6-O-sulfate results in decreased expression of FABP4 mRNA CTD PMID:19520133 beta-naphthoflavone multiple interactions ISO RGD:69309 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FABP4 mRNA CTD PMID:18164116 bexarotene increases expression ISO RGD:733454 6480464 bexarotene results in increased expression of FABP4 mRNA, bexarotene results in increased expression of FABP4 protein CTD PMID:21622945 , PMID:25932594 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of FABP4 mRNA CTD PMID:12759900 bezafibrate increases expression ISO RGD:69309 6480464 Bezafibrate results in increased expression of FABP4 mRNA CTD PMID:11473052 bezafibrate increases expression ISO RGD:733454 6480464 Bezafibrate results in increased expression of FABP4 mRNA CTD PMID:21324916 bezafibrate multiple interactions ISO RGD:733454 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP4 mRNA] CTD PMID:21324916 bicalutamide multiple interactions EXP 6480464 bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein] CTD PMID:18801408 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:733454 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 more ... bis(2-ethylhexyl) phthalate affects expression ISO RGD:733454 6480464 Diethylhexyl Phthalate affects the expression of FABP4 mRNA CTD PMID:25351189 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733454 6480464 Diethylhexyl Phthalate results in increased expression of FABP4 mRNA CTD PMID:19245819 more ... bisphenol A multiple interactions ISO RGD:733454 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA] more ... CTD PMID:15659569 more ... bisphenol A decreases expression ISO RGD:733454 6480464 bisphenol A results in decreased expression of FABP4 mRNA CTD PMID:30133442 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FABP4 mRNA CTD PMID:30352284 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FABP4 mRNA, bisphenol A results in increased expression of FABP4 protein CTD PMID:24418828 more ... bisphenol A affects expression ISO RGD:69309 6480464 bisphenol A affects the expression of FABP4 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:733454 6480464 bisphenol A results in increased expression of FABP4 more ... CTD PMID:15659569 more ... bisphenol A decreases expression ISO RGD:69309 6480464 bisphenol A results in decreased expression of FABP4 mRNA CTD PMID:26088557 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 fulvestrant inhibits the reaction [bisphenol A results in increased expression of FABP4 protein] CTD PMID:24418828 bisphenol A multiple interactions ISO RGD:69309 6480464 [Fructose co-treated with bisphenol A] results in increased expression of FABP4 protein CTD PMID:26930160 Bisphenol A diglycidyl ether increases expression EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of FABP4 mRNA CTD PMID:22763116 Bisphenol A diglycidyl ether increases expression ISO RGD:733454 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of FABP4 mRNA CTD PMID:22763116 bleomycin A2 decreases expression ISO RGD:733454 6480464 Bleomycin results in decreased expression of FABP4 mRNA CTD PMID:29408570 boric acid multiple interactions ISO RGD:733454 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA] more ... CTD PMID:28285642 Butylbenzyl phthalate multiple interactions ISO RGD:733454 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FABP4 mRNA CTD PMID:26820058 Butylbenzyl phthalate increases expression ISO RGD:733454 6480464 butylbenzyl phthalate results in increased expression of FABP4 mRNA CTD PMID:24155963 , PMID:27923775 cadmium atom increases expression ISO RGD:69309 6480464 Cadmium results in increased expression of FABP4 mRNA CTD PMID:17327700 cadmium dichloride increases expression ISO RGD:69309 6480464 Cadmium Chloride results in increased expression of FABP4 mRNA CTD PMID:17327700 , PMID:25993096 caffeine decreases expression ISO RGD:733454 6480464 Caffeine results in decreased expression of FABP4 mRNA CTD PMID:23727198 caffeine decreases expression ISO RGD:69309 6480464 Caffeine results in decreased expression of FABP4 mRNA CTD PMID:23727198 calcitriol multiple interactions ISO RGD:733454 6480464 Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA] more ... CTD PMID:17959142 , PMID:9564879 calcitriol decreases expression ISO RGD:733454 6480464 Calcitriol results in decreased expression of FABP4 mRNA, Calcitriol results in decreased expression of FABP4 protein CTD PMID:16368784 more ... capsaicin multiple interactions ISO RGD:69309 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of FABP4 mRNA], Capsaicin inhibits the reaction [Dietary Fats results in increased expression of FABP4 protein] CTD PMID:20359164 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of FABP4 mRNA CTD PMID:18533110 carbon nanotube decreases expression ISO RGD:733454 6480464 Nanotubes, Carbon analog results in decreased expression of FABP4 mRNA CTD PMID:25620056 carbon nanotube multiple interactions ISO RGD:733454 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FABP4 mRNA CTD PMID:25926378 carbon nanotube increases expression ISO RGD:69309 6480464 Nanotubes, Carbon results in increased expression of FABP4 mRNA CTD PMID:19836432 carbon nanotube increases expression ISO RGD:733454 6480464 Nanotubes, Carbon analog results in increased expression of FABP4 mRNA, Nanotubes, Carbon results in increased expression of FABP4 mRNA CTD PMID:25554681 , PMID:25620056 celastrol affects expression ISO RGD:733454 6480464 tripterine affects the expression of FABP4 mRNA CTD PMID:27085773 ceric oxide increases expression ISO RGD:69309 6480464 ceric oxide results in increased expression of FABP4 mRNA CTD PMID:29463257 chitosan multiple interactions ISO RGD:69309 6480464 [Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA], Chitosan inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA] CTD PMID:28987369 chloroacetaldehyde affects expression EXP 6480464 chloroacetaldehyde affects the expression of FABP4 mRNA CTD PMID:25596134 choline multiple interactions ISO RGD:733454 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of FABP4 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA CTD PMID:20938992 , PMID:29127188 ciglitazone increases expression ISO RGD:733454 6480464 ciglitazone results in increased expression of FABP4 mRNA CTD PMID:16847310 ciguatoxin CTX1B affects expression ISO RGD:733454 6480464 Ciguatoxins affects the expression of FABP4 mRNA CTD PMID:18353800 ciprofibrate increases expression ISO RGD:733454 6480464 ciprofibrate results in increased expression of FABP4 mRNA CTD PMID:12771043 cisplatin decreases expression ISO RGD:69309 6480464 Cisplatin results in decreased expression of FABP4 mRNA CTD PMID:22023808 Citreoviridin multiple interactions ISO RGD:733454 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA], Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 Citreoviridin multiple interactions ISO RGD:69309 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA], Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 Citreoviridin decreases expression ISO RGD:69309 6480464 citreoviridin results in decreased expression of FABP4 mRNA CTD PMID:31419397 Citreoviridin decreases expression ISO RGD:733454 6480464 citreoviridin results in decreased expression of FABP4 mRNA CTD PMID:31419397 clofibrate multiple interactions ISO RGD:733454 6480464 [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA more ... CTD PMID:8536680 , PMID:9543393 clofibrate decreases expression ISO RGD:733454 6480464 Clofibrate results in decreased expression of FABP4 mRNA CTD PMID:21392566 clofibric acid affects expression ISO RGD:69309 6480464 Clofibric Acid affects the expression of FABP4 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FABP4 mRNA CTD PMID:12032628 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of FABP4 mRNA CTD PMID:12860252 corticosterone multiple interactions EXP 6480464 [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein, Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 cortisone increases expression ISO RGD:733454 6480464 Cortisone results in increased expression of FABP4 mRNA CTD PMID:21315688 cortisone multiple interactions ISO RGD:733454 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:21315688 cucurbitacin B decreases expression ISO RGD:733454 6480464 cucurbitacin B results in decreased expression of FABP4 mRNA CTD PMID:24316209 cucurbitacin I decreases expression ISO RGD:733454 6480464 cucurbitacin I results in decreased expression of FABP4 mRNA CTD PMID:24316209 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of FABP4 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:733454 6480464 Cyclosporine results in decreased expression of FABP4 mRNA CTD PMID:19770486 cyproterone acetate multiple interactions EXP 6480464 [Cyproterone Acetate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein, Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 D-glucose multiple interactions ISO RGD:733454 6480464 [Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA more ... CTD PMID:8536680 daidzein increases expression ISO RGD:733454 6480464 daidzein results in increased expression of FABP4 mRNA CTD PMID:30920877 daidzein multiple interactions ISO RGD:733454 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [daidzein results in increased expression of FABP4 mRNA] CTD PMID:30920877 DDE multiple interactions EXP 6480464 Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA] CTD PMID:26200599 DDT increases expression EXP 6480464 DDT results in increased expression of FABP4 mRNA CTD PMID:25014179 desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of FABP4 mRNA CTD PMID:12032628 dexamethasone multiple interactions ISO RGD:733454 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA] more ... CTD PMID:11812925 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FABP4 mRNA, Dexamethasone results in increased expression of FABP4 protein CTD PMID:19853017 more ... dexamethasone increases expression ISO RGD:733454 6480464 Dexamethasone results in increased expression of FABP4 mRNA, Dexamethasone results in increased expression of FABP4 protein CTD PMID:22956630 more ... dexamethasone multiple interactions ISO RGD:69309 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of FABP4 mRNA CTD PMID:21350315 dexamethasone multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] more ... CTD PMID:20206132 more ... dexamethasone phosphate multiple interactions EXP 6480464 [dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 dextran sulfate multiple interactions ISO RGD:733454 6480464 [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA CTD PMID:26271895 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FABP4 protein CTD PMID:30218697 dibutylstannane increases expression ISO RGD:733454 6480464 di-n-butyltin results in increased expression of FABP4 mRNA CTD PMID:29787037 dibutylstannane multiple interactions ISO RGD:733454 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of FABP4 mRNA] CTD PMID:29787037 dibutylstannane increases expression EXP 6480464 di-n-butyltin results in increased expression of FABP4 mRNA CTD PMID:29787037 dibutylstannane multiple interactions EXP 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of FABP4 mRNA] CTD PMID:29787037 dichlorine multiple interactions ISO RGD:69309 6480464 [Ozone co-treated with Chlorine] results in increased expression of FABP4 mRNA CTD PMID:18636392 diethyl sulfate multiple interactions EXP 6480464 diethyl sulfate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 diethylstilbestrol increases expression ISO RGD:733454 6480464 Diethylstilbestrol results in increased expression of FABP4 mRNA CTD PMID:22710028 dihydroresveratrol decreases expression EXP 6480464 dihydroresveratrol results in decreased expression of FABP4 CTD PMID:21852083 diosgenin multiple interactions ISO RGD:733454 6480464 Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA] more ... CTD PMID:26408789 diosgenin decreases expression ISO RGD:733454 6480464 Diosgenin results in decreased expression of FABP4 mRNA CTD PMID:26408789 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of FABP4 mRNA CTD PMID:12032628 dioxygen increases expression ISO RGD:733454 6480464 Oxygen deficiency results in increased expression of FABP4 mRNA CTD PMID:20880076 disodium selenite multiple interactions ISO RGD:69309 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 disodium selenite increases expression ISO RGD:69309 6480464 Sodium Selenite results in increased expression of FABP4 mRNA CTD PMID:31419397 disodium selenite multiple interactions ISO RGD:733454 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 divanadium pentaoxide decreases expression ISO RGD:733454 6480464 vanadium pentoxide results in decreased expression of FABP4 mRNA CTD PMID:26210822 doxorubicin increases expression ISO RGD:733454 6480464 Doxorubicin results in increased expression of FABP4 mRNA CTD PMID:22016648 equilin multiple interactions EXP 6480464 Equilin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 ethanol decreases expression ISO RGD:733454 6480464 Ethanol results in decreased expression of FABP4 mRNA CTD PMID:15513904 , PMID:22173916 ethanol multiple interactions ISO RGD:733454 6480464 rosiglitazone inhibits the reaction [Ethanol results in decreased expression of FABP4 mRNA] CTD PMID:22173916 ethyl 3,4-dihydroxybenzoate multiple interactions ISO RGD:733454 6480464 ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of FABP4 mRNA] CTD PMID:24338020 ethylparaben increases expression ISO RGD:733454 6480464 ethyl-p-hydroxybenzoate results in increased expression of FABP4 mRNA CTD PMID:22956630 farnesol increases expression EXP 6480464 Farnesol results in increased expression of FABP4 mRNA CTD PMID:30806763 fenofibrate increases expression ISO RGD:733454 6480464 Fenofibrate results in increased expression of FABP4 mRNA CTD PMID:11798191 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of FABP4 mRNA CTD PMID:12759900 , PMID:25572481 fipronil increases expression ISO RGD:733454 6480464 fipronil results in increased expression of FABP4 mRNA CTD PMID:27103584 fluprostenol multiple interactions ISO RGD:733454 6480464 fluprostenol inhibits the reaction [Niacin results in increased expression of FABP4 mRNA] CTD PMID:21236357 folic acid multiple interactions ISO RGD:733454 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of FABP4 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA CTD PMID:20938992 , PMID:29127188 fructose multiple interactions ISO RGD:69309 6480464 [Fructose co-treated with bisphenol A] results in increased expression of FABP4 protein CTD PMID:26930160 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein], fulvestrant inhibits the reaction [bisphenol A results in increased expression of FABP4 protein] CTD PMID:24418828 , PMID:27003841 fulvestrant multiple interactions ISO RGD:733454 6480464 fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of FABP4 protein], fulvestrant inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA] CTD PMID:26018136 , PMID:26408789 furan increases expression ISO RGD:69309 6480464 furan results in increased expression of FABP4 mRNA CTD PMID:26194646 genistein multiple interactions ISO RGD:733454 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Genistein results in increased expression of FABP4 mRNA] CTD PMID:30920877 genistein increases expression ISO RGD:733454 6480464 Genistein results in increased expression of FABP4 mRNA CTD PMID:30920877 geraniol increases expression EXP 6480464 geraniol results in increased expression of FABP4 mRNA CTD PMID:30806763 ginsenoside Re increases expression ISO RGD:733454 6480464 ginsenoside Re results in increased expression of FABP4 mRNA CTD PMID:23545455 glafenine increases expression ISO RGD:69309 6480464 Glafenine results in increased expression of FABP4 mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:733454 6480464 [Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA more ... CTD PMID:8536680 glycerol 2-phosphate multiple interactions ISO RGD:733454 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA, [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA CTD PMID:25062436 glycerol 2-phosphate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA CTD PMID:25932594 graphite affects expression ISO RGD:69309 6480464 Graphite affects the expression of FABP4 mRNA CTD PMID:29933104 guggulsterone multiple interactions ISO RGD:733454 6480464 Calcitriol promotes the reaction [pregna-4 more ... CTD PMID:17959142 guggulsterone decreases expression ISO RGD:733454 6480464 pregna-4 more ... CTD PMID:17959142 GW 6471 multiple interactions ISO RGD:733454 6480464 GW 6471 inhibits the reaction [PPARA protein promotes the reaction [GW 7647 results in increased expression of FABP4 mRNA]] CTD PMID:21324916 GW 6471 decreases expression ISO RGD:733454 6480464 GW 6471 results in decreased expression of FABP4 mRNA CTD PMID:21324916 GW 7647 multiple interactions ISO RGD:733454 6480464 GW 6471 inhibits the reaction [PPARA protein promotes the reaction [GW 7647 results in increased expression of FABP4 mRNA]] more ... CTD PMID:21324916 GW 7647 increases expression ISO RGD:733454 6480464 GW 7647 results in increased expression of FABP4 mRNA CTD PMID:21324916 harmine multiple interactions ISO RGD:733454 6480464 [phenylamil co-treated with Harmine] results in increased expression of FABP4 mRNA CTD PMID:20519739 hesperetin decreases expression EXP 6480464 hesperetin results in decreased expression of FABP4 mRNA CTD PMID:25345581 hydrazines decreases expression ISO RGD:733454 6480464 Hydrazines results in decreased expression of FABP4 mRNA, Hydrazines results in decreased expression of FABP4 protein CTD PMID:21647536 hydroxytyrosol decreases expression ISO RGD:733454 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of FABP4 mRNA CTD PMID:21569430 ibuprofen decreases expression EXP 6480464 Ibuprofen results in decreased expression of FABP4 mRNA CTD PMID:17070997 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of FABP4 mRNA CTD PMID:25596134 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:733454 6480464 indeno(1 more ... CTD PMID:26377693 indole-3-methanol affects expression ISO RGD:69309 6480464 indole-3-carbinol affects the expression of FABP4 mRNA CTD PMID:21396975 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP4 mRNA more ... CTD PMID:23086663 , PMID:28628672 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of FABP4 mRNA CTD PMID:15273253 iopamidol increases expression EXP 6480464 Iopamidol results in increased expression of FABP4 mRNA CTD PMID:29705293 isoliquiritigenin multiple interactions ISO RGD:733454 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of FABP4 protein] CTD PMID:27117918 isonicotinamide decreases expression ISO RGD:733454 6480464 isonicotinamide results in decreased expression of FABP4 mRNA CTD PMID:16813520 isonicotinamide increases expression ISO RGD:733454 6480464 isonicotinamide results in increased expression of FABP4 mRNA CTD PMID:16813520 isotretinoin increases expression ISO RGD:69309 6480464 Isotretinoin results in increased expression of FABP4 mRNA CTD PMID:19212007 ivermectin multiple interactions ISO RGD:733454 6480464 Rosiglitazone affects the reaction [Ivermectin affects the expression of FABP4 mRNA] CTD PMID:31199990 ivermectin affects expression ISO RGD:733454 6480464 Ivermectin affects the expression of FABP4 mRNA CTD PMID:31199990 L-ascorbic acid multiple interactions ISO RGD:733454 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA, [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA CTD PMID:25062436 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA CTD PMID:25932594 L-methionine multiple interactions ISO RGD:733454 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of FABP4 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA CTD PMID:20938992 , PMID:29127188 lead diacetate decreases expression ISO RGD:733454 6480464 lead acetate results in decreased expression of FABP4 mRNA CTD PMID:22609695 lead diacetate affects methylation ISO RGD:69309 6480464 lead acetate affects the methylation of FABP4 gene CTD PMID:29571894 lead diacetate increases expression ISO RGD:69309 6480464 lead acetate results in increased expression of FABP4 mRNA CTD PMID:29571894 lead(0) increases expression ISO RGD:733454 6480464 Lead results in increased expression of FABP4 CTD PMID:23086611 lead(0) increases expression ISO RGD:69309 6480464 Lead results in increased expression of FABP4 mRNA CTD PMID:23086611 lead(2+) increases expression ISO RGD:733454 6480464 Lead results in increased expression of FABP4 CTD PMID:23086611 lead(2+) increases expression ISO RGD:69309 6480464 Lead results in increased expression of FABP4 mRNA CTD PMID:23086611 levonorgestrel multiple interactions EXP 6480464 [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein, Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 Licarin A multiple interactions ISO RGD:733454 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of FABP4 mRNA CTD PMID:29288687 linoleic acid affects localization ISO RGD:733454 6480464 Linoleic Acid analog affects the localization of FABP4 protein CTD PMID:27939595 lipopolysaccharide increases expression ISO RGD:733454 6480464 Lipopolysaccharides results in increased expression of FABP4 mRNA, Lipopolysaccharides results in increased expression of FABP4 protein CTD PMID:15705927 , PMID:27339419 lipopolysaccharide decreases expression ISO RGD:733454 6480464 Lipopolysaccharides results in decreased expression of FABP4 mRNA CTD PMID:16847310 LY294002 multiple interactions ISO RGD:733454 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA] CTD PMID:15659569 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of FABP4 mRNA CTD PMID:20738756 Melengestrol acetate multiple interactions EXP 6480464 [Melengestrol Acetate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 methotrexate increases expression ISO RGD:69309 6480464 Methotrexate results in increased expression of FABP4 mRNA CTD PMID:25187349 methotrexate multiple interactions ISO RGD:69309 6480464 Leucovorin inhibits the reaction [Methotrexate results in increased expression of FABP4 protein] CTD PMID:25187349 methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FABP4 mRNA CTD PMID:30806763 mifepristone multiple interactions ISO RGD:733454 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA] CTD PMID:27145005 mifepristone increases expression ISO RGD:733454 6480464 Mifepristone results in increased expression of FABP4 protein CTD PMID:26018136 mifepristone multiple interactions EXP 6480464 [Mifepristone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein more ... CTD PMID:24418828 more ... mono(2-ethylhexyl) phthalate increases expression ISO RGD:733454 6480464 mono-(2-ethylhexyl)phthalate analog results in increased expression of FABP4 mRNA more ... CTD PMID:25543134 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:733454 6480464 Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein] CTD PMID:27117918 N-nitrosodiethylamine multiple interactions ISO RGD:69309 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FABP4 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:733454 6480464 Diethylnitrosamine results in increased expression of FABP4 mRNA CTD PMID:12771043 , PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:69309 6480464 Diethylnitrosamine results in increased expression of FABP4 mRNA CTD PMID:19638242 naringin multiple interactions ISO RGD:733454 6480464 naringin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA] CTD PMID:22198281 nicotinic acid multiple interactions ISO RGD:733454 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 mRNA more ... CTD PMID:21236357 norethisterone multiple interactions EXP 6480464 Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 norgestrel multiple interactions EXP 6480464 [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein, Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of FABP4 CTD PMID:20590410 oleic acid multiple interactions ISO RGD:733454 6480464 [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA, [Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA CTD PMID:8536680 oleic acid affects localization ISO RGD:733454 6480464 Oleic Acid analog affects the localization of FABP4 protein CTD PMID:27939595 oleic acid increases expression EXP 6480464 Oleic Acid results in increased expression of FABP4 mRNA CTD PMID:26739624 osthole increases expression ISO RGD:733454 6480464 osthol results in increased expression of FABP4 mRNA CTD PMID:19682441 oxaliplatin multiple interactions ISO RGD:69309 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FABP4 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:69309 6480464 oxaliplatin results in increased expression of FABP4 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:69309 6480464 [Ozone co-treated with Chlorine] results in increased expression of FABP4 mRNA CTD PMID:18636392 paracetamol affects expression ISO RGD:733454 6480464 Acetaminophen affects the expression of FABP4 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FABP4 mRNA CTD PMID:21420995 perfluorobutanesulfonic acid increases expression ISO RGD:733454 6480464 perfluorobutanesulfonic acid results in increased expression of FABP4 mRNA CTD PMID:30031040 perfluorohexanesulfonic acid increases expression ISO RGD:733454 6480464 perfluorohexanesulfonic acid results in increased expression of FABP4 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69309 6480464 perfluorooctane sulfonic acid results in increased expression of FABP4 mRNA CTD PMID:22237054 perfluorooctane-1-sulfonic acid increases expression ISO RGD:733454 6480464 perfluorooctane sulfonic acid results in increased expression of FABP4 mRNA CTD PMID:21705711 , PMID:26548598 perfluorooctanoic acid increases expression ISO RGD:733454 6480464 perfluorooctanoic acid results in increased expression of FABP4 mRNA CTD PMID:18467677 , PMID:30657992 perfluorooctanoic acid increases expression ISO RGD:69309 6480464 perfluorooctanoic acid results in increased expression of FABP4 mRNA CTD PMID:19162173 perfluorooctanoic acid multiple interactions ISO RGD:733454 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of FABP4 mRNA] more ... CTD PMID:18467677 , PMID:29094436 permethrin increases expression ISO RGD:733454 6480464 Permethrin results in increased expression of FABP4 mRNA CTD PMID:24911977 phenacetin increases expression ISO RGD:69309 6480464 Phenacetin results in increased expression of FABP4 mRNA CTD PMID:17698508 phenobarbital multiple interactions ISO RGD:733454 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FABP4 mRNA] CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of FABP4 mRNA CTD PMID:19084549 phenobarbital increases expression ISO RGD:733454 6480464 Phenobarbital results in increased expression of FABP4 mRNA CTD PMID:19482888 Phenylamil multiple interactions ISO RGD:733454 6480464 [phenylamil co-treated with Harmine] results in increased expression of FABP4 mRNA, PPARG protein promotes the reaction [phenylamil results in increased expression of FABP4 mRNA] CTD PMID:20519739 Phenylamil increases expression ISO RGD:733454 6480464 phenylamil results in increased expression of FABP4 mRNA CTD PMID:20519739 phenylephrine decreases expression ISO RGD:69309 6480464 Phenylephrine results in decreased expression of FABP4 mRNA CTD PMID:18158353 phenylhydrazine increases expression ISO RGD:69309 6480464 phenylhydrazine results in increased expression of FABP4 mRNA CTD PMID:17698508 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FABP4 protein CTD PMID:30218697 pioglitazone multiple interactions EXP 6480464 [pioglitazone co-treated with Tretinoin] results in increased expression of FABP4 mRNA CTD PMID:16573735 pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of FABP4 mRNA CTD PMID:15273253 more ... pioglitazone increases expression ISO RGD:733454 6480464 pioglitazone results in increased expression of FABP4 mRNA CTD PMID:12927809 more ... pioglitazone multiple interactions ISO RGD:733454 6480464 pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA] CTD PMID:15273253 pirinixic acid multiple interactions ISO RGD:733454 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of FABP4 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of FABP4 mRNA] CTD PMID:18467677 more ... pirinixic acid increases expression ISO RGD:733454 6480464 pirinixic acid results in increased expression of FABP4 mRNA CTD PMID:11798191 more ... platycodin D decreases expression ISO RGD:733454 6480464 platycodin D results in decreased expression of FABP4 mRNA, platycodin D results in decreased expression of FABP4 protein CTD PMID:20024897 more ... platycodin D multiple interactions ISO RGD:733454 6480464 CTNNB1 affects the reaction [platycodin D results in decreased expression of FABP4 protein] CTD PMID:21798269 poly(I:C) increases expression ISO RGD:733454 6480464 Poly I-C results in increased expression of FABP4 mRNA CTD PMID:15705927 potassium dichromate decreases expression ISO RGD:733454 6480464 Potassium Dichromate results in decreased expression of FABP4 mRNA CTD PMID:23608068 prednisone multiple interactions EXP 6480464 [Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 prochloraz decreases expression EXP 6480464 prochloraz results in decreased expression of FABP4 mRNA CTD PMID:30879083 progesterone increases expression ISO RGD:733454 6480464 Progesterone results in increased expression of FABP4 mRNA CTD PMID:15713686 progesterone increases expression ISO RGD:69309 6480464 Progesterone results in increased expression of FABP4 mRNA CTD PMID:21770760 propylparaben increases expression ISO RGD:733454 6480464 propylparaben results in increased expression of FABP4 mRNA CTD PMID:22956630 , PMID:24155963 prostaglandin D2 increases expression ISO RGD:733454 6480464 Prostaglandin D2 results in increased expression of FABP4 mRNA CTD PMID:9543393 prostaglandin F2alpha multiple interactions ISO RGD:733454 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 mRNA, [Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 protein CTD PMID:21236357 pyocyanine decreases expression ISO RGD:733454 6480464 Pyocyanine results in decreased expression of FABP4 mRNA CTD PMID:31078726 quartz increases expression ISO RGD:69309 6480464 Quartz results in increased expression of FABP4 mRNA CTD PMID:19836432 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of FABP4 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:733454 6480464 Raloxifene Hydrochloride results in increased expression of FABP4 mRNA CTD PMID:16643890 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of FABP4 CTD PMID:21852083 resveratrol multiple interactions ISO RGD:733454 6480464 Rosiglitazone inhibits the reaction [Resveratrol results in decreased expression of FABP4 mRNA] more ... CTD PMID:23525482 , PMID:30920877 resveratrol decreases expression ISO RGD:733454 6480464 Resveratrol results in decreased expression of FABP4 mRNA, Resveratrol results in decreased expression of FABP4 protein CTD PMID:16813520 more ... resveratrol affects secretion EXP 6480464 resveratrol affects the secretion of FABP4 protein CTD PMID:24802182 Ro 41-5253 increases expression ISO RGD:733454 6480464 Ro 41-5253 results in increased expression of FABP4 mRNA CTD PMID:17290005 rofecoxib decreases expression EXP 6480464 rofecoxib results in decreased expression of FABP4 mRNA CTD PMID:17070997 rotenone increases expression ISO RGD:733454 6480464 Rotenone results in increased expression of FABP4 mRNA CTD PMID:22016648 sildenafil citrate multiple interactions ISO RGD:733454 6480464 8-(4-chlorophenylthio)guanosine 3', 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of FABP4 protein] CTD PMID:20471953 sildenafil citrate increases expression ISO RGD:733454 6480464 Sildenafil Citrate results in increased expression of FABP4 mRNA, Sildenafil Citrate results in increased expression of FABP4 protein CTD PMID:20471953 silibinin multiple interactions ISO RGD:733454 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein] CTD PMID:25559859 silicon dioxide increases expression ISO RGD:733454 6480464 Silicon Dioxide results in increased expression of FABP4 mRNA CTD PMID:19073995 , PMID:29203145 silicon dioxide increases expression ISO RGD:69309 6480464 Silicon Dioxide results in increased expression of FABP4 mRNA CTD PMID:22431001 silicon dioxide affects expression EXP 6480464 Silicon Dioxide analog affects the expression of FABP4 mRNA CTD PMID:23806026 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of FABP4 mRNA CTD PMID:20371982 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of FABP4 mRNA CTD PMID:28595984 sodium arsenite affects expression ISO RGD:733454 6480464 sodium arsenite affects the expression of FABP4 mRNA CTD PMID:28206643 sodium arsenite decreases expression ISO RGD:733454 6480464 sodium arsenite results in decreased expression of FABP4 mRNA CTD PMID:21512104 , PMID:22700541 sodium arsenite multiple interactions ISO RGD:733454 6480464 sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA] CTD PMID:11812925 sodium dichromate increases expression ISO RGD:69309 6480464 sodium bichromate results in increased expression of FABP4 mRNA CTD PMID:25993096 sodium dodecyl sulfate increases expression EXP 6480464 Sodium Dodecyl Sulfate results in increased expression of FABP4 mRNA CTD PMID:30806763 sodium fluoride decreases expression ISO RGD:733454 6480464 Sodium Fluoride results in decreased expression of FABP4 mRNA CTD PMID:27862939 spironolactone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 splitomicin multiple interactions ISO RGD:733454 6480464 splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 mRNA], splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 protein] CTD PMID:23525482 streptozocin multiple interactions ISO RGD:733454 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of FABP4 mRNA CTD PMID:29127188 succimer multiple interactions ISO RGD:733454 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA CTD PMID:21641980 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA CTD PMID:26378955 sulfasalazine increases expression ISO RGD:733454 6480464 Sulfasalazine results in increased expression of FABP4 mRNA CTD PMID:22016648 sulforaphane increases expression ISO RGD:733454 6480464 sulforafan results in increased expression of FABP4 mRNA CTD PMID:30529165 sulindac sulfide multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP4 protein], PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein] CTD PMID:17602619 , PMID:18665581 sulindac sulfide increases expression EXP 6480464 sulindac sulfide analog results in increased expression of FABP4 protein CTD PMID:17602619 , PMID:18665581 tamoxifen decreases expression ISO RGD:733454 6480464 Tamoxifen results in decreased expression of FABP4 protein CTD PMID:27358406 tauroursodeoxycholic acid decreases expression EXP 6480464 tauroursodeoxycholic acid results in decreased expression of FABP4 mRNA CTD PMID:24312631 Tesaglitazar increases expression ISO RGD:69309 6480464 tesaglitazar results in increased expression of FABP4 mRNA CTD PMID:21515302 tetrachloromethane increases expression ISO RGD:69309 6480464 Carbon Tetrachloride results in increased expression of FABP4 mRNA CTD PMID:16239168 tetrachloromethane increases expression ISO RGD:733454 6480464 Carbon Tetrachloride results in increased expression of FABP4 mRNA CTD PMID:17484886 , PMID:27339419 tetracycline decreases expression ISO RGD:733454 6480464 Tetracycline results in decreased expression of FABP4 mRNA CTD PMID:16917069 thiamine(1+) chloride multiple interactions ISO RGD:733454 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 thiamine(1+) chloride increases expression ISO RGD:69309 6480464 Thiamine results in increased expression of FABP4 mRNA CTD PMID:31419397 thiamine(1+) chloride multiple interactions ISO RGD:69309 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 thioacetamide increases expression ISO RGD:69309 6480464 Thioacetamide results in increased expression of FABP4 mRNA CTD PMID:23411599 Thiocarbohydrazide multiple interactions EXP 6480464 thiocarbohydrazide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 titanium dioxide affects expression ISO RGD:733454 6480464 titanium dioxide affects the expression of FABP4 mRNA CTD PMID:23557971 tolylfluanid multiple interactions EXP 6480464 N-dichlorofluoromethylthio-N', N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 topotecan increases expression ISO RGD:69309 6480464 Topotecan results in increased expression of FABP4 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:69309 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FABP4 mRNA CTD PMID:25729387 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of FABP4 mRNA CTD PMID:26705709 triamcinolone multiple interactions EXP 6480464 [Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein CTD PMID:29782964 tributylstannane multiple interactions ISO RGD:733454 6480464 diazepinylbenzoic acid inhibits the reaction [tributyltin results in increased expression of FABP4 mRNA] more ... CTD PMID:22197818 more ... tributylstannane multiple interactions EXP 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of FABP4 mRNA] CTD PMID:29787037 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of FABP4 mRNA CTD PMID:28011154 , PMID:29787037 tributylstannane increases expression ISO RGD:733454 6480464 tributyltin results in increased expression of FABP4 mRNA, tributyltin results in increased expression of FABP4 protein CTD PMID:15993011 more ... trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of FABP4 mRNA CTD PMID:26705709 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of FABP4 mRNA CTD PMID:22726953 triflumizole multiple interactions EXP 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA, T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA] CTD PMID:23086663 triflumizole increases expression ISO RGD:733454 6480464 triflumizol results in increased expression of FABP4 mRNA CTD PMID:23086663 triflumizole multiple interactions ISO RGD:733454 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA, T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA] CTD PMID:23086663 triphenyl phosphate multiple interactions ISO RGD:733454 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA CTD PMID:25062436 triphenyl phosphate multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA] more ... CTD PMID:28437481 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of FABP4 mRNA, triphenyl phosphate results in increased expression of FABP4 protein CTD PMID:28934090 triphenylstannane increases expression ISO RGD:733454 6480464 triphenyltin results in increased expression of FABP4 mRNA CTD PMID:25777084 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of FABP4 mRNA, troglitazone results in increased expression of FABP4 protein CTD PMID:10097144 more ... troglitazone multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 mRNA] more ... CTD PMID:27003841 , PMID:28437481 troglitazone increases expression ISO RGD:733454 6480464 troglitazone results in increased expression of FABP4 mRNA CTD PMID:10871190 more ... troglitazone increases expression ISO RGD:69309 6480464 troglitazone results in increased expression of FABP4 mRNA CTD PMID:21515302 , PMID:21877759 troglitazone multiple interactions ISO RGD:733454 6480464 [troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA, troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA] CTD PMID:10871190 , PMID:11089532 tungsten multiple interactions ISO RGD:733454 6480464 Tungsten promotes the reaction [rosiglitazone results in increased expression of FABP4 mRNA] CTD PMID:26865663 tungsten increases expression ISO RGD:733454 6480464 Tungsten results in increased expression of FABP4 mRNA CTD PMID:26865663 tunicamycin increases expression ISO RGD:733454 6480464 Tunicamycin results in increased expression of FABP4 mRNA CTD PMID:17127020 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of FABP4 mRNA CTD PMID:24312631 valproic acid increases expression ISO RGD:733454 6480464 Valproic Acid results in increased expression of FABP4 mRNA CTD PMID:24489787 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FABP4 mRNA CTD PMID:29501571 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of FABP4 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FABP4 mRNA CTD PMID:23179753 valsartan decreases expression EXP 6480464 Valsartan results in decreased expression of FABP4 mRNA CTD PMID:22768174 zidovudine affects expression EXP 6480464 Zidovudine affects the expression of FABP4 mRNA CTD PMID:20032539 zinc atom multiple interactions EXP 6480464 IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA], MT1A gene polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA] CTD PMID:18316168 zinc atom increases expression ISO RGD:69309 6480464 Zinc deficiency results in increased expression of FABP4 mRNA CTD PMID:11717422 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of FABP4 mRNA CTD PMID:18316168 zinc(0) multiple interactions EXP 6480464 IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA], MT1A gene polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA] CTD PMID:18316168 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of FABP4 mRNA CTD PMID:18316168 zinc(0) increases expression ISO RGD:69309 6480464 Zinc deficiency results in increased expression of FABP4 mRNA CTD PMID:11717422
Gene-Chemical Interaction Annotations
